While these studies suggest that IL-17 producing T cells may contribute to a pro-inflammatory milieu, which can predispose to chronic liver disease, the role of IL-23 signaling in NASH pathogenesis has not been fully dissected. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatohepatitis.